Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics.
belief updating
ego dissolution
hierarchical predictive coding
precision
psychedelics
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
12
2021
accepted:
02
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Evidence suggests classic psychedelics reduce the precision of belief updating and enable access to a range of alternate hypotheses that underwrite how we make sense of the world. This process, in the higher cortices, has been postulated to explain the therapeutic efficacy of psychedelics for the treatment of internalizing disorders. We argue reduced precision also underpins change to consciousness, known as "
Identifiants
pubmed: 35368271
doi: 10.3389/fnins.2022.827400
pmc: PMC8968396
doi:
Types de publication
Journal Article
Langues
eng
Pagination
827400Informations de copyright
Copyright © 2022 Stoliker, Egan and Razi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2743-2748
pubmed: 30692255
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
pubmed: 2124706
Sci Rep. 2017 Oct 13;7(1):13187
pubmed: 29030624
Nat Rev Neurosci. 2020 Nov;21(11):611-624
pubmed: 32929261
Neural Netw. 2003 Nov;16(9):1325-52
pubmed: 14622888
Behav Brain Sci. 2007 Dec;30(5-6):481-99; discussion 499-548
pubmed: 18366828
N Engl J Med. 2021 Apr 15;384(15):1402-1411
pubmed: 33852780
J Psychopharmacol. 2015 Mar;29(3):241-53
pubmed: 25670401
Neuroimage. 2020 Apr 1;209:116462
pubmed: 31857204
Brain. 2010 Apr;133(Pt 4):1265-83
pubmed: 20194141
Pharmacol Rev. 2021 Jan;73(1):202-277
pubmed: 33328244
ACS Pharmacol Transl Sci. 2020 Dec 10;4(2):568-572
pubmed: 33861219
Front Pharmacol. 2018 Jan 17;8:974
pubmed: 29387009
Curr Drug Abuse Rev. 2014;7(3):157-64
pubmed: 25563443
Ann N Y Acad Sci. 1957 Mar 14;66(3):418-34
pubmed: 13425232
Philos Trans R Soc Lond B Biol Sci. 2015 May 19;370(1668):
pubmed: 25823866
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8
pubmed: 27071089
Psychol Rev. 2009 Jan;116(1):252-82
pubmed: 19159156
J Neurosci. 2013 Sep 18;33(38):15171-83
pubmed: 24048847
J Psychopharmacol. 2014 Nov;28(11):983-92
pubmed: 25213996
J Neurosci. 2007 Feb 28;27(9):2349-56
pubmed: 17329432
Neuropsychopharmacology. 2012 Feb;37(3):630-40
pubmed: 21956447
Pharmacol Rev. 2019 Jul;71(3):316-344
pubmed: 31221820
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12569-74
pubmed: 18723676
Trends Cogn Sci. 2000 Jan;4(1):14-21
pubmed: 10637618
Amino Acids. 2012 Jun;42(6):2039-57
pubmed: 21947614
Neuron. 1999 Sep;24(1):49-65, 111-25
pubmed: 10677026
Trends Cogn Sci. 2013 Nov;17(11):565-73
pubmed: 24126130
Ann Neurol. 2015 Oct;78(4):594-605
pubmed: 26290126
Front Hum Neurosci. 2016 Jun 14;10:269
pubmed: 27378878
Nat Rev Neurosci. 2010 Feb;11(2):127-38
pubmed: 20068583
Trends Neurosci. 2004 Dec;27(12):712-9
pubmed: 15541511
Neurosci Biobehav Rev. 2014 Apr;41:85-97
pubmed: 23416066
PLoS Comput Biol. 2008 Nov;4(11):e1000211
pubmed: 18989391
Schizophr Bull. 2013 Nov;39(6):1343-51
pubmed: 23044373
Nat Neurosci. 1999 Jan;2(1):79-87
pubmed: 10195184
Philos Trans R Soc Lond B Biol Sci. 2009 May 12;364(1521):1211-21
pubmed: 19528002
PLoS One. 2009 Jul 29;4(7):e6421
pubmed: 19641614
Neurology. 2014 Sep 16;83(12):1112-8
pubmed: 25128179
J Physiol Paris. 2006 Jul-Sep;100(1-3):70-87
pubmed: 17097864
J Psychopharmacol. 2007 Jan;21(1):50-64
pubmed: 16714323
Front Hum Neurosci. 2013 Sep 12;7:547
pubmed: 24062658
Front Neurosci. 2019 Oct 31;13:1169
pubmed: 31749675
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82
pubmed: 11209064
Hum Brain Mapp. 2015 Aug;36(8):3137-53
pubmed: 26010878
Front Pharmacol. 2018 Mar 02;9:172
pubmed: 29568270
J Neurosci. 2015 Dec 16;35(50):16300-2
pubmed: 26674857
Neuron. 2007 Oct 25;56(2):209-25
pubmed: 17964241
Front Psychol. 2012 Apr 02;3:96
pubmed: 22485102
Sci Rep. 2020 Oct 20;10(1):17725
pubmed: 33082424
Eur Neuropsychopharmacol. 2016 Jul;26(7):1099-109
pubmed: 27084302
Front Hum Neurosci. 2017 May 23;11:245
pubmed: 28588463
Front Psychiatry. 2021 Sep 10;12:724606
pubmed: 34566723
PLoS One. 2012;7(2):e30800
pubmed: 22363492
Trends Cogn Sci. 2009 Jan;13(1):7-13
pubmed: 19058991
Front Hum Neurosci. 2014 Feb 03;8:20
pubmed: 24550805
Neuron. 2012 Nov 21;76(4):695-711
pubmed: 23177956
Curr Biol. 2016 Apr 25;26(8):1043-50
pubmed: 27085214
Neurosci Conscious. 2021 Oct 13;2021(2):niab038
pubmed: 34650816
Curr Biol. 2021 Sep 13;31(17):R1026-R1032
pubmed: 34520708
J R Soc Interface. 2014 Dec 6;11(101):20140873
pubmed: 25401177
Front Comput Neurosci. 2018 Nov 13;12:90
pubmed: 30483088
Front Psychiatry. 2013 May 30;4:47
pubmed: 23750138
Annu Rev Neurosci. 2007;30:57-78
pubmed: 17417935
Behav Brain Sci. 2013 Jun;36(3):181-204
pubmed: 23663408
Neuropsychopharmacology. 2017 Oct;42(11):2105-2113
pubmed: 28443617
Front Psychol. 2018 Sep 04;9:1475
pubmed: 30245648
Neuropharmacology. 2018 Nov;142:167-178
pubmed: 29548884
Ann N Y Acad Sci. 2008 Mar;1124:1-38
pubmed: 18400922
Trends Cogn Sci. 2007 Jan;11(1):16-22
pubmed: 17129748
Psychopharmacology (Berl). 2015 Oct;232(19):3663-76
pubmed: 26231498